Legal analysis: Generally, artificial livers cannot be reimbursed normally during liver transplantation or crystal processing, but the hospitalization expenses and other related drug expenses during the treatment period can be based on the hospital level and individual medical insurance purchase level.

Different reimbursements are carried out accordingly. Therefore, when artificial liver treatment is involved, medical insurance can indeed reimburse some items and expenses, but it cannot reimburse all expenses.

Therefore, when a patient has severe liver disease and must undergo artificial liver treatment, the proportion borne by himself is basically as high as more than 80%. However, when an individual undergoes artificial liver treatment, the cost will increase significantly due to the number of times and can reach tens of thousands.

From the above, we can know that medical insurance can only reimburse a small part of the treatment costs during artificial liver treatment, so the cost of this treatment is still relatively high.

Legal basis: Article 2 of the "Social Insurance Law of the People's Republic of China" The state establishes basic pension insurance, basic medical insurance, work-related injury insurance, unemployment insurance, maternity insurance and other social insurance systems to protect citizens in the event of old age, illness, work-related injury,

The right to obtain material assistance from the state and society in accordance with the law in cases of unemployment, childbirth, etc.

Article 26 The treatment standards of basic medical insurance for employees, new rural cooperative medical insurance and basic medical insurance for urban residents shall be implemented in accordance with national regulations.

Article 28 Medical expenses that comply with the basic medical insurance drug catalog, diagnosis and treatment items, medical service facility standards, and emergency and rescue expenses shall be paid from the basic medical insurance fund in accordance with national regulations.